Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | INSM |
---|---|---|
09:32 ET | 19331 | 27.765 |
09:33 ET | 10743 | 27.9 |
09:35 ET | 8655 | 28.01 |
09:37 ET | 47363 | 28.165 |
09:39 ET | 5624 | 27.995 |
09:42 ET | 24293 | 28.105 |
09:44 ET | 10064 | 28 |
09:46 ET | 6958 | 28.01 |
09:48 ET | 7719 | 28.11 |
09:50 ET | 13858 | 28.15 |
09:51 ET | 2600 | 28.12 |
09:53 ET | 18932 | 27.91 |
09:55 ET | 3700 | 27.765 |
09:57 ET | 1000 | 27.84 |
10:00 ET | 2200 | 27.84 |
10:02 ET | 12384 | 27.925 |
10:04 ET | 7095 | 27.94 |
10:06 ET | 3072 | 27.92 |
10:08 ET | 1737 | 27.965 |
10:09 ET | 3382 | 27.95 |
10:11 ET | 2373 | 27.915 |
10:13 ET | 1500 | 27.88 |
10:15 ET | 3610 | 27.9 |
10:18 ET | 4800 | 27.89 |
10:20 ET | 2000 | 27.9 |
10:22 ET | 2607 | 27.855 |
10:24 ET | 1200 | 27.88 |
10:26 ET | 3590 | 27.95 |
10:27 ET | 2728 | 27.92 |
10:29 ET | 200 | 27.915 |
10:31 ET | 3183 | 27.87 |
10:33 ET | 2179 | 27.785 |
10:36 ET | 3269 | 27.745 |
10:38 ET | 3700 | 27.62 |
10:40 ET | 6134 | 27.67 |
10:42 ET | 400 | 27.665 |
10:44 ET | 400 | 27.72 |
10:45 ET | 3243 | 27.79 |
10:47 ET | 5652 | 27.795 |
10:49 ET | 2170 | 27.745 |
10:51 ET | 13488 | 27.805 |
10:54 ET | 30560 | 27.79 |
10:56 ET | 2880 | 27.765 |
10:58 ET | 900 | 27.74 |
11:00 ET | 27410 | 27.64 |
11:02 ET | 6124 | 27.745 |
11:03 ET | 1400 | 27.78 |
11:05 ET | 2865 | 27.73 |
11:07 ET | 2315 | 27.8 |
11:09 ET | 3556 | 27.74 |
11:12 ET | 1169 | 27.69 |
11:14 ET | 4357 | 27.62 |
11:16 ET | 1269 | 27.62 |
11:18 ET | 3150 | 27.545 |
11:20 ET | 1398 | 27.525 |
11:21 ET | 42156 | 27.65 |
11:23 ET | 8741 | 27.59 |
11:25 ET | 846 | 27.55 |
11:27 ET | 2400 | 27.55 |
11:30 ET | 4269 | 27.53 |
11:32 ET | 17765 | 27.55 |
11:34 ET | 4312 | 27.575 |
11:36 ET | 1200 | 27.59 |
11:38 ET | 3900 | 27.59 |
11:39 ET | 2900 | 27.57 |
11:41 ET | 2497 | 27.495 |
11:43 ET | 4204 | 27.47 |
11:45 ET | 2900 | 27.54 |
11:48 ET | 4549 | 27.525 |
11:50 ET | 3549 | 27.48 |
11:52 ET | 1700 | 27.49 |
11:54 ET | 15179 | 27.57 |
11:56 ET | 5475 | 27.56 |
11:57 ET | 3200 | 27.6 |
11:59 ET | 2520 | 27.665 |
12:01 ET | 4212 | 27.68 |
12:03 ET | 2400 | 27.65 |
12:06 ET | 2400 | 27.61 |
12:08 ET | 1400 | 27.615 |
12:10 ET | 2304 | 27.625 |
12:12 ET | 800 | 27.585 |
12:14 ET | 900 | 27.55 |
12:15 ET | 2794 | 27.54 |
12:17 ET | 3438 | 27.585 |
12:19 ET | 2500 | 27.575 |
12:21 ET | 1730 | 27.575 |
12:24 ET | 1000 | 27.51 |
12:26 ET | 1976 | 27.52 |
12:28 ET | 1300 | 27.55 |
12:30 ET | 1900 | 27.6 |
12:32 ET | 3312 | 27.57 |
12:33 ET | 781 | 27.56 |
12:35 ET | 1134 | 27.57 |
12:37 ET | 600 | 27.56 |
12:39 ET | 609 | 27.575 |
12:42 ET | 11354 | 27.61 |
12:44 ET | 1182 | 27.61 |
12:46 ET | 6424 | 27.655 |
12:48 ET | 2603 | 27.6 |
12:50 ET | 2445 | 27.64 |
12:51 ET | 1300 | 27.64 |
12:53 ET | 1900 | 27.62 |
12:55 ET | 1700 | 27.69 |
12:57 ET | 3200 | 27.7 |
01:00 ET | 2479 | 27.76 |
01:02 ET | 16698 | 27.75 |
01:04 ET | 2163 | 27.725 |
01:06 ET | 1800 | 27.73 |
01:08 ET | 4247 | 27.69 |
01:09 ET | 1108 | 27.73 |
01:11 ET | 300 | 27.75 |
01:13 ET | 1889 | 27.78 |
01:15 ET | 2790 | 27.78 |
01:18 ET | 1348 | 27.8 |
01:20 ET | 800 | 27.8 |
01:22 ET | 2353 | 27.79 |
01:24 ET | 2867 | 27.82 |
01:26 ET | 3425 | 27.83 |
01:27 ET | 4520 | 27.855 |
01:29 ET | 3833 | 27.87 |
01:31 ET | 2988 | 27.825 |
01:33 ET | 900 | 27.83 |
01:36 ET | 5338 | 27.8375 |
01:38 ET | 1904 | 27.85 |
01:40 ET | 4400 | 27.84 |
01:42 ET | 2980 | 27.795 |
01:44 ET | 1154 | 27.8 |
01:45 ET | 4870 | 27.81 |
01:47 ET | 1400 | 27.815 |
01:49 ET | 3472 | 27.74 |
01:51 ET | 608 | 27.76 |
01:54 ET | 1779 | 27.78 |
01:56 ET | 4000 | 27.79 |
01:58 ET | 3713 | 27.765 |
02:00 ET | 2213 | 27.75 |
02:02 ET | 3989 | 27.695 |
02:03 ET | 4345 | 27.68 |
02:05 ET | 2750 | 27.73 |
02:07 ET | 1100 | 27.75 |
02:09 ET | 1600 | 27.75 |
02:12 ET | 18115 | 27.81 |
02:14 ET | 1700 | 27.79 |
02:16 ET | 3200 | 27.79 |
02:18 ET | 2661 | 27.815 |
02:20 ET | 2000 | 27.81 |
02:21 ET | 1960 | 27.83 |
02:23 ET | 3876 | 27.82 |
02:25 ET | 2345 | 27.785 |
02:27 ET | 800 | 27.795 |
02:30 ET | 6579 | 27.85 |
02:32 ET | 3029 | 27.84 |
02:34 ET | 100 | 27.825 |
02:36 ET | 2269 | 27.85 |
02:38 ET | 1455 | 27.85 |
02:39 ET | 2388 | 27.84 |
02:41 ET | 3337 | 27.87 |
02:43 ET | 4300 | 27.85 |
02:45 ET | 2595 | 27.81 |
02:48 ET | 1736 | 27.83 |
02:50 ET | 5083 | 27.825 |
02:52 ET | 2948 | 27.845 |
02:54 ET | 1200 | 27.86 |
02:56 ET | 1000 | 27.85 |
02:57 ET | 2628 | 27.855 |
02:59 ET | 2933 | 27.86 |
03:01 ET | 3302 | 27.82 |
03:03 ET | 1606 | 27.82 |
03:06 ET | 3344 | 27.82 |
03:08 ET | 2058 | 27.82 |
03:10 ET | 2179 | 27.84 |
03:12 ET | 3316 | 27.83 |
03:14 ET | 7783 | 27.87 |
03:15 ET | 3831 | 27.87 |
03:17 ET | 1500 | 27.905 |
03:19 ET | 4041 | 27.855 |
03:21 ET | 3078 | 27.87 |
03:24 ET | 3264 | 27.88 |
03:26 ET | 2730 | 27.89 |
03:28 ET | 6671 | 27.9 |
03:30 ET | 23848 | 27.955 |
03:32 ET | 6648 | 27.935 |
03:33 ET | 9526 | 27.955 |
03:35 ET | 1400 | 27.9 |
03:37 ET | 8171 | 27.91 |
03:39 ET | 20275 | 28 |
03:42 ET | 14677 | 27.995 |
03:44 ET | 8542 | 28.055 |
03:46 ET | 6899 | 28.06 |
03:48 ET | 17245 | 28.03 |
03:50 ET | 9791 | 27.995 |
03:51 ET | 19732 | 28 |
03:53 ET | 17558 | 27.985 |
03:55 ET | 22345 | 28 |
03:57 ET | 48428 | 27.99 |
04:00 ET | 290690 | 27.96 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Insmed Inc | 3.9B | -5.3x | --- |
Immunocore Holdings PLC | 2.7B | -40.9x | --- |
Blueprint Medicines Corp | 4.5B | -8.0x | --- |
Amicus Therapeutics Inc | 3.4B | -18.9x | --- |
Revolution Medicines Inc | 4.0B | -7.5x | --- |
Mirati Therapeutics Inc | 4.0B | -4.6x | --- |
Insmed Incorporated is a biopharmaceutical company. It is engaged in providing ARIKAYCE (amikacin liposome inhalation suspension) product, which is used for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its clinical-stage pipeline includes brensocatib and treprostinil palmitil inhalation powder (TPIP). Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1, which is developed for the treatment of patients with bronchiectasis, cystic fibrosis (CF) and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRS) and hidradenitis suppurativa (HS). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil which offers a differentiated product profile for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.9B |
---|---|
Revenue (TTM) | $280.8M |
Shares Outstanding | 143.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.22 |
EPS | $-5.27 |
Book Value | $0.65 |
P/E Ratio | -5.3x |
Price/Sales (TTM) | 14.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -243.16% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.